Singapore markets closed

PAVmed Inc. (PAVM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.3000-0.0090 (-2.91%)
At close: 04:00PM EST
0.2800 -0.02 (-6.67%)
After hours: 04:11PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 36.23M
Enterprise value 62.64M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)20.13
Price/book (mrq)7.42
Enterprise value/revenue 41.35
Enterprise value/EBITDA -0.76

Trading information

Stock price history

Beta (5Y monthly) 0.79
52-week change 3-55.29%
S&P500 52-week change 314.90%
52-week high 30.7180
52-week low 30.2000
50-day moving average 30.2737
200-day moving average 30.3706

Share statistics

Avg vol (3-month) 3623k
Avg vol (10-day) 3539.1k
Shares outstanding 5120.76M
Implied shares outstanding 6120.76M
Float 8113.7M
% held by insiders 19.12%
% held by institutions 19.72%
Shares short (14 Nov 2023) 43.27M
Short ratio (14 Nov 2023) 49.72
Short % of float (14 Nov 2023) 42.87%
Short % of shares outstanding (14 Nov 2023) 42.71%
Shares short (prior month 12 Oct 2023) 43.66M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin 0.00%
Operating margin (ttm)-1,963.08%

Management effectiveness

Return on assets (ttm)-83.91%
Return on equity (ttm)-1,358.06%

Income statement

Revenue (ttm)1.51M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)940.80%
Gross profit (ttm)-3.24M
EBITDA -73.92M
Net income avi to common (ttm)-70.9M
Diluted EPS (ttm)-0.7000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)30.99M
Total cash per share (mrq)0.26
Total debt (mrq)49.91M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.60
Book value per share (mrq)-0.39

Cash flow statement

Operating cash flow (ttm)-56.98M
Levered free cash flow (ttm)-29.53M